 |
Ruben Krupik
Chief Executive Officer
In addition to his position as CEO, Ruben is responsible for defining the vision, strategy and direction of the Company. Ruben serves as active chairman in D-pharm, CureTech, Mediwound and Andromeda.
An accomplished, multi-disciplinary industry executive and visionary, Ruben was a key driver in the launch of numerous successful companies in the fields of medical technology (Given Imaging, Galil Medical), image processing (3DV), broadband and software. With a wide-ranging entrepreneurial track record, he is well experienced in the complex process of transforming promising ideas into thriving companies.
He served as President and CEO of RDC, which specializes in identifying commercially viable technologies within Rafael and forming start-up companies around them. Formerly, Ruben held senior positions in Tadiran Telecommunication Group where he accrued extensive experience in high-tech management.
Ruben holds an LLB from the Faculty of Law of the Tel Aviv University and B.A.s in Economics and Political Science both from the Hebrew University of Jerusalem.
|
|
 |
|
|
| |
Board Members |
|
|
|
|
|
|
| |
 |
|
Avi Fischer - Chairman of the Board |
|
|
| |
|
|
Dr. Aharon Schwartz |
|
|
| |
|
|
Dr. Gabi Barabash |
|
|
| |
|
|
Dr. Tamar Manor |
|
|
| |
|
|
Dr. Udi Raanani |
|
|
| |
|
|
Avi Zigelman |
|
|
| |
|
|
Yoni Kaplan |
|
|
|
|
